CTLA4 and gastric cancer: Currently, immune checkpoint inhibitor (ICI) treatment such as anti-cytotoxic T-lymphocyte antigen 4 (CTLA4) mAb and anti-programmed death-1 (PD-1) mAbs is considered as an innovative treatment strategy for advanced GC [2].